Active, not recruitingObservationalNCT03765450 ↗Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
Enrolling by invitationObservationalNCT05718570 ↗A Multi-national, Multi-centre, Prospective, Single-arm, Observational, Non-interventional Post-authorisation Safety Study to Investigate Long-term Safety of Sogroya® (Somapacitan) in Adults With Growth Hormone Deficiency (AGHD) Under Routine Clinical PracticeGeorgiana Alina DobriPIInterventionDrug: SomapacitanDatesFeb 2023 – Dec 2032 (est.)SponsorNovo Nordisk Pharmaceuticals, Inc.Adult Growth Hormone Deficiency
Active, not recruitingObservationalNCT05911763 ↗Prospective, Observational , Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients With Hemophilia ACatherine McGuinnPIInterventionDrug: Efanesoctocog Alfa BIVV001DatesJun 2023 – Jun 2028 (est.)SponsorSanofi S.A.Hemophilia A
Active, not recruitingObservationalNCT06693531 ↗A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of CareAliza B SolomonPIInterventionDrug: dupilumabDatesNov 2024 – May 2030 (est.)SponsorRegeneron Pharmaceuticals, Inc.Eosinophilic Esophagitis (EoE)
CompletedObservationalNCT05835219 ↗REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational StudyCarl V. CrawfordPIInterventionDrug: REBYOTA™DatesJun 2023 – Aug 2025SponsorFerring Pharmaceuticals, Inc.Recurrence of Clostridium Difficile Infection
TerminatedObservationalNCT06092970 ↗Clinical Protocol REN-007E - Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Subjects Enrolled in Study REN-007Charles Anthony MackPIInterventionDrug: RBT-1 · Drug: PlaceboDatesOct 2023 – Feb 2026SponsorRenibus Therapeutics, Inc.Post-Operative Complications in Cardiac Surgery